The role of corticosteroids in the treatment of pain in cancer patients

Current Pain and Headache Reports

Volumn 16, Issue 4, 2012, Pages 307-313

  Leppert, W ^a   Buss, T ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adjuvant analgesics; Cancer; Corticosteroids; Opioids; Pain

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; GLYCOPYRRONIUM BROMIDE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; STEROID;

ANOREXIA; ANTINOCICEPTION; ARTICLE; BONE PAIN; BRAIN METASTASIS; CANCER PAIN; CANCER PATIENT; CANCER SURVIVAL; CANDIDIASIS; CUSHING SYNDROME; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPEPSIA; DYSPHAGIA; HICCUP; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; IMMUNE DEFICIENCY; INCREASED APPETITE; INSOMNIA; INTESTINE OBSTRUCTION; INTRACRANIAL HYPERTENSION; INTRACTABLE PAIN; MENTAL DISEASE; METASTASIS; MOON FACE; MUSCLE WEAKNESS; MYOPATHY; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NONHUMAN; OSTEOPOROSIS; PEPTIC ULCER; PROSTATE CANCER; PURPURA; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; RESTLESSNESS; RISK BENEFIT ANALYSIS; SLEEP DISORDER; SPINAL CORD COMPRESSION; SUPERIOR CAVA VEIN OBSTRUCTION; SURVIVAL TIME; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; ANALGESICS; FEMALE; HUMANS; MALE; NEOPLASMS; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION;

EID: 84865622736     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-012-0273-z     Document Type: Article

References (43)

1. World Health Organisation. Cancer pain relief and palliative care. Geneva: World Health Organisation; 1996.
2. Caraceni A. The EPCRC project to revise the European Association for Palliative Care (EAPC) guidelines on the use of opioids for cancer pain. Palliat Med. 2011;25:389-90.
3. •• Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N et al., for the European Palliative Care Research Collaborative (EPCRC) on behalf of the European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58-e68. This paper presents current EAPC recommendations on the use of opioids in the treatment of pain in cancer patients.
4. Shvartzman P, Friger M, Shani A, Barak F, Yoram C, Singer Y. Pain control in ambulatory cancer patients-can we do better? J Pain Symptom Manag. 2003;26:716-22. (Pubitemid 36952347)
5. Leppert W. Progress in pharmacological pain treatment with opioid analgesics. Wspolcz Onkol-Contemp Oncol. 2009;13:66-73.
6. Eidelman A, White T, Swarm RA. Interventional therapies for cancer pain management: Important adjuvants to systemic analgesics. J Nat Compr Cancer Net. 2007;5:753-60. (Pubitemid 47492772)
7. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist. 2004;9:571-91. (Pubitemid 39332322)
8. Leppert W. Pain management in patients with cancer: Focus on opioid analgesics. Curr Pain Head Rep. 2011;15:271-9.
9. Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105-15.
10. Aron DC, Findling JW, Tyrell B. Glucocorticoids and adrenal androgens. In: Gardner DG, Shoback D, editors. Greenspan's Basic and clinical endocrinology. 8th ed. New York: McGraw Hill; 2007. pp. 346-396.
11. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams Textbook of endocrinology. Philadelphia: Saunders; 2002. p. 491-507.
12. Richter B, Neises G, Clar C. Glucocorticoid withdrawal schemes in chronic medical disorders-a systematic review. Endocrinol Metabol Clin N Am. 2002;31(3):751.
13. Livanou T, Ferriman D, James VHT. Recovery of hypotalamopituitary-adrenal function after corticosteroid therapy. Lancet. 1967;2(7521):856.
14. Watanabe S, Bruera E. Corticosteroids as adjuvant analgesics. J Pain Symptom Manag. 1994;9:442-5. (Pubitemid 24338145)
15. Mensah-Nyagan AG, Meyer L, Schaeffer V, Kibaly C, Patte-Mensah C. Evidence for a key role of steroids in the modulation of pain. Psychoneuroendocrinology. 2009;34 Suppl 1:S169-77.
16. Yamada K, Ushio Y, Hayakawa T, Arita N, Yamada N, Mogami H. Effects of methylprednisolone on peritumoral brain oedema-a quantitive autoradiographic study. J Neurosurg. 1983;59:612-9. (Pubitemid 13008559)
17. Posner JB, Howieson J, Cvitkovic E. Disappearing spinal-cord compression-oncolytic effect of glucocorticoids (and other chemiotherapeutic agents) on epidural metastases. Ann Neurol. 1977;2:409-13. (Pubitemid 8400441)
18. Mensah-Nyagan AG, Kibaly C, Schaeffer V, Venard C, Meyer L, Patte-Mensah C. Endogenous steroid production in the spinal cord and potential involvement in neuropathic pain modulation. J Steroid Biochem Molecul Biol. 2008;109:286-93. (Pubitemid 351711685)
19. Aloisi AM. Gonadal hormones and sex differences in pain reactivity. Clin J Pain. 2003;19:168-74. (Pubitemid 36578517)
20. Aloisi AM, Bonifazi M. Sex hormones, central nervous system and pain. Hormon Behav. 2006;50:1-7. (Pubitemid 43792491)
21. Liu NJ, Gintzler AR. Prolonged ovarian sex steroid treatment of male rats produces antinociception: Identification of sex-based divergent analgesic mechanisms. Pain. 2000;85:273-81. (Pubitemid 30110769)
22. Lundström SH, Furst CJ. The use of corticosteroids in Swedish palliative care. Acta Oncol. 2006;45:430-7. (Pubitemid 43884611)
23. Bernard SA, Bruera E. Drug interactions in palliative care. J Clin Oncol. 2000;18:1780-99. (Pubitemid 30220558)
24. Hardy JR, Rees E, Ling J, Burman R, Feuer D, Broadley K, et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med. 2001;15:3-8. (Pubitemid 32103352)
25. Gannon C, McNamara P. A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manag. 2002;24:328-34. (Pubitemid 35379715)
26. Exton L, Walsh D, Caraceni AT, Fainsinger R, Foley K, Glare P, et al. Corticosteroids. In: Palliative medicine. Philadelphia: Elsevier; 2009. p. 797-801.
27. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease-role of nonsteroidal antiinflammatory drugs. Ann Intern Med. 1991;114:735-40.
28. Sturdza A, Millar BA, Bana N, Laperriere N, Pond G,Wong RKS, et al. The use and toxicity of steroids in the management of patients with brain metastases. Support Care Cancer. 2008;16:1041-8.
29. Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer-a prospective analysis of current practice. Postgrad Med J. 1983;59:702-6. (Pubitemid 14235540)
30. • Kang JH, Hiu D, Kim MJ, Kim HG, KangMH, Lee GW, Bruera E. Corticosteroid rotation to alleviate dexamethasone-induced hiccup: A case series at a single institution. J Pain Symptom Manage. 2012;43:625-630. This case series presents a new approach to the treatment of dexamethasone-induced hiccup.
31. Dickman A, Schneider J, Varga J. The Syringe driver: Continuous subcutaneous infusions in palliative care. Oxford: Oxford University Press; 2005.
32. Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, et al. Drugs in palliative care: Results from a representative survey in Germany. Palliat Med. 2004;18:100-7. (Pubitemid 38380026)
33. Yennurajalingam S, Urbauer DL, Casper KLB, Reyes-Gibby CC, Chacko R, Poulter V. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manag. 2011;41:49-56.
34. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednizolone in terminal cancer patients-a prospective, randomized double-blind study. Cancer Treat Rep. 1985;69:751-4. (Pubitemid 15229409)
35. Dellacuna GR, Pellegrini A, Piazzi M. Effect of methylprednizolone sodium succinate on quality of life in preterminal cancer patients-a placebo controlled, multicenter study. Eur J Cancer Clin Oncol. 1989;25:1817-21. (Pubitemid 20084182)
36. Popiela T, Lucchi R, Giongo F. Methylpredinsolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol. 1989;25:1823-9. (Pubitemid 20084183)
37. Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W. Treatment of metastatic prostatic cancer with low-dose prednisone-evaluation of psin and quality of life as prgmatic indexes of response. J Clin Oncol. 1989;7:590-7. (Pubitemid 19126794)
38. Greenberg HS, Kim JH, Posner JB. Epidural spinal-cord compresion from metastatic tumor-results with a new treatment protocol. Ann Neurol. 1980;8:361-6. (Pubitemid 11238281)
39. Kozin F, Ryan LM, Carerra GF, Soin JS, Wortmann RL. The reflex sympathetic dystrophy syndrome (RSDS) III. Scintigraphic studies, further evidence for therapeutic efficacy of systemic corticosteroids and proposed diagnostic criteria. Am J Med. 1981;70:23-30. (Pubitemid 11183512)
40. Arkel YS, Lakelewin D, Savopoulos AA, Berman E. Bone-lesions in hairy cell leukemia-a case report and response of bone pains to steroids. Cancer. 1984;53:2401-3. (Pubitemid 14102477)
41. • Vyvey M. Steroids as pain relief adjuvants. Can Fam Phys. 2010;56:1295-1297. This case report presents a patient with severe bone and neuropathic cancer pain and benefits and risks associated with the use of dexamethasone as an addition to opioid therapy.
42. Moertel CG, Schutt AJ, Reitemei RJ, Hahn RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer. 1974;33:1607-9.
43. Vecht CJ, Haaxmareiche H, Vanputten WLJ, Devisser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal-cord compression. Neurology. 1989;39:1255-7. (Pubitemid 19239735)